Nasdaq cprx.

Hedge fund activity in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) At the end of the third quarter, a total of 12 of the hedge funds tracked by Insider Monkey held long positions in this stock, a ...Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is a Florida-based commercial-stage biopharmaceutical company that focuses on therapies for rare debilitating, chronic neuromuscular, and neurological ...Find the latest news headlines from Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) at Nasdaq.com.Aug 2, 2023 · Fintel reports that on August 11, 2023, Cantor Fitzgerald maintained coverage of Catalyst Pharmaceuticals (NASDAQ:CPRX) with a Overweight recommendation. Analyst Price Forecast Suggests 52.12% Upside

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) was founded in 2002 and generated its first profits in 2019. The 10-year results are summarized below. CPRX …

Turning to the calls side of the option chain, the call contract at the $15.00 strike price has a current bid of $1.70. If an investor was to purchase shares of CPRX stock at the current price ...The Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) share price has done very well over the last month, posting an excellent gain of 27%. Looking back a bit further, it's encouraging to see the stock ...

Noteworthy ETF Inflows: XBI, BBIO, HALO, CPRX. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ...That number of contracts represents approximately 900,900 underlying shares, working out to a sizeable 56.5% of CPRX's average daily trading volume over the past month, of 1.6 million shares.Shares of NASDAQ:CPRX opened at $14.82 on Monday. The stock has a market capitalization of $1.58 billion, a price-to-earnings ratio of 28.50 and a beta of 1.11. …Catalyst Pharmaceuticals, Inc. (CPRX.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Catalyst Pharmaceuticals, Inc ...See the latest Catalyst Pharmaceuticals Inc stock price (CPRX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Nov 10, 2023 · Earnings vs Savings Rate: CPRX's forecast earnings growth (25.8% per year) is above the savings rate (2.2%). Earnings vs Market: CPRX's earnings (25.8% per year) are forecast to grow faster than the US market (14.7% per year). High Growth Earnings: CPRX's earnings are expected to grow significantly over the next 3 years.

AlSimonov/iStock via Getty Images. This is my fifth Catalyst (NASDAQ:CPRX) article following 04/2023's "Catalyst Pharmaceuticals: Fixing Its Misnomer Is No Easy Task".My concern with Catalyst is ...

CPRX: NASDAQ (Stock) CATALYST PHARMACEUTICALS, INC. DEC 01, 11:00 AM EST $14.82 +0% Dividend (Fwd) $0.00 Yield (Fwd) Annualized forward dividend yield. Multiplies the ...Back to CPRX Overview About Latest Pre-Market Trades Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.... Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. Copyright 2023 Zacks Investment Research | 10 S Riverside Plaza ...Aug 27, 2022 · Anyone interested in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) should probably be aware that the Chief Commercial Officer, Jeffrey Del Carmen, recently divested US$199k worth of shares in the ... Find the latest dividend history for Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) at Nasdaq.com.09/26/2022. 5.23%. 95,058,928. 4,970,704. 7,496,361. 1. Data brought to you by Benzinga APIs. Looking for the most shorted stocks? Short interest for Catalyst Pharmaceuticals gives investors a ...

Catalyst Pharmaceuticals Inc (CPRX) Stock Price & News - Google Finance. Home CPRX • NASDAQ. Catalyst Pharmaceuticals Inc. Follow. Share. $14.06. After Hours: $13.71. …TipRanks | Stock Market Research, News and Analyst Forecasts ... The stock of Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) has increased by 5.94 when compared to last closing price of 12.63.Despite this, the company has seen a gain of 4.12% in its stock price over the last five trading days. Zacks Investment Research reported 2023-11-09 that Catalyst (CPRX) reports mixed third-quarter results.Firdapse is also being studied in a proof-of-concept spinal muscular atrophy type-3 study, with top-line data expected before year-end. CPRX closed Monday's trading at $4.26, up 5.31%.NasdaqCM:CPRX Insider Trading Volume August 29th 2021. I will like Catalyst Pharmaceuticals better if I see some big insider buys. While we wait, check out this free list of growing companies with ...

Nov 25, 2023 · LPL Financial LLC trimmed its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 49.6% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,878 shares of the biopharmaceutical company’s stock after selling 33,334 shares during the […] Aug 25, 2022 · NasdaqCM:CPRX Earnings and Revenue Growth August 25th 2022 Investors should note that institutions actually own more than half the company, so they can collectively wield significant power.

Catalyst Pharmaceuticals has a total shareholder equity of $348.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $413.2M and $64.7M respectively. Catalyst Pharmaceuticals's EBIT is $75.9M making its interest coverage ratio -13.9. It has cash and short-term investments of $121.0M.Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) dropped 7.5% during mid-day trading on Friday . The company traded as low as $12.43 and last traded at $12.43. Approximately ...Find the latest dividend history for Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) at Nasdaq.com.Mar 16, 2023 · Catalyst Pharmaceuticals, Inc. CPRX reported earnings of 22 cents per share for the fourth quarter of 2022, marginally beating the Zacks Consensus Estimate of 21 cents. Earnings were also higher ... See historical performance and comparison. View Valuation. Research Catalyst Pharmaceuticals' (Nasdaq:CPRX) stock price, latest news & stock analysis. …Jul 30, 2021 · You can take a look at the company's revenue and earnings growth trend, in the chart below. To see the actual numbers, click on the chart. NasdaqCM:CPRX Earnings and Revenue History July 30th 2021 The average twelve-month price prediction for Catalyst Pharmaceuticals is $24.75 with a high price target of $27.00 and a low price target of $24.00. Learn more on CPRX's analyst rating history. Do Wall Street analysts like Catalyst Pharmaceuticals more than its competitors? Analysts like Catalyst Pharmaceuticals more than other Medical companies.Jul 3, 2023 · Catalyst Pharmaceuticals had non-GAAP profits of 41 cents, a full dime a share over the consensus. On a GAAP basis, earnings were 26 cents a share for the quarter, an improvement of 117% from ...

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) · Latest CPRX News | Press Releases · Today's Trading · Growth & Valuation · Competitors · Financials · Profile · Forecasts.

Mar 16, 2023 · Catalyst Pharmaceuticals, Inc. CPRX reported earnings of 22 cents per share for the fourth quarter of 2022, marginally beating the Zacks Consensus Estimate of 21 cents. Earnings were also higher ...

(NASDAQ:CPRX), announced on June 20, 2023 [1]. The proceeds from the agreement extend Santhera's cash reach into 2025. Together with the expected income ...Catalyst Pharmaceuticals last released its quarterly earnings data on November 8th, 2023. The biopharmaceutical company reported ($0.26) earnings per share for the quarter, hitting the consensus estimate of ($0.26). The business earned $102.69 million during the quarter, compared to the consensus estimate of $100.17 million.Shares of Catalyst Pharmaceutical (CPRX) have gained 8.4% over the past four weeks to close the last trading session at $16.53, but there could still be a solid upside left in the stock if short ...Stock analysis for Catalyst Pharmaceuticals Inc (CPRX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Most readers would already be aware that Catalyst Pharmaceuticals' (NASDAQ:CPRX) stock increased significantly by 9.4% over the past month. Since the market usually pay for a company’s long-term ...The stock price of Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) has dropped by -10.68 compared to previous close of 13.44. Despite this, the company has seen a fall of -6.21% in its stock price over the last five trading days. GlobeNewsWire reported 2023-10-23 that The Company to Host a Conference CaFintel reports that on August 11, 2023, Cantor Fitzgerald maintained coverage of Catalyst Pharmaceuticals (NASDAQ:CPRX) with a Overweight recommendation. Analyst Price Forecast Suggests 52.12% UpsideMar 16, 2023 · Catalyst Pharmaceuticals, Inc. CPRX reported earnings of 22 cents per share for the fourth quarter of 2022, marginally beating the Zacks Consensus Estimate of 21 cents. Earnings were also higher ... Swiss National Bank raised its stake in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 2.4% in the 2nd quarter, Holdings Channel …

Find the latest Revenue & EPS data for Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) at Nasdaq.com.Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q4 2022 Earnings Conference Call March 16, 2023 8:30 AM ETCompany Participants. Alicia Grande - VP, CFO, and Treasurer. Patrick J. McEnany - Chairman ...ADVISORY, Aug. 18, 2015 (GLOBE NEWSWIRE) --What: Catalyst Pharmaceuticals (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with ...Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with..Instagram:https://instagram. friday onlinerail stocksbest reit funds 2023ford and gm Catalyst Pharmaceutical (CPRX) came out with quarterly earnings of $0.20 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.16 per share a year ago.Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) Earnings Report Date | Nasdaq. Created with Sketch. *The upcoming earnings date is derived from an algorithm based on a company's historical ... how to transfer insurance to new carwhat to trade crypto Catalyst Pharmaceuticals, Inc. (CPRX) NasdaqCM - NasdaqCM Real Time Price. Currency in USD. Follow. 2W 10W 9M. 14.82 +0.39 (+2.70%) At close: 04:00PM EST. 14.85 +0.03 …Cetera Investment Advisers grew its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 7.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).The fund owned 15,223 shares of the biopharmaceutical company’s stock after acquiring an … home loans for people on disability CORAL GABLES, Fla., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced the …Catalyst Pharmaceuticals (NASDAQ:CPRX) and Ironwood Pharmaceuticals (NASDAQ:IRWD) are both small-cap medical companies, but which is the superior business?We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, community ranking, valuation, institutional ownership, …